Palatin Technologies
We discover and develop novel therapeutics for patients living with inflammatory and autoimmune conditions.
General Information
Get notified when Palatin Technologies moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Palatin Technologies
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
Biotechnology
AI Insight
Bounce Watch AIPalatin Technologies continues to secure significant post-IPO equity funding, most recently raising $10M in January 2024 and $5M in October 2023. These capital infusions are crucial for advancing its biopharmaceutical pipeline, particularly the Phase 3 clinical trials for PL9643 in dry eye disease and planned proof-of-concept studies. The company's announced plan to begin trading on Nasdaq in May 2026, despite its existing public status, suggests a strategic move to enhance market visibility or facilitate future capital acquisition.
About Palatin Technologies
Taxonomy: biopharmaceutical, therapeutics, medical research, melanocortin system, inflammatory conditions, autoimmune conditions, ophthalmic indications, clinical trials, FDA approval, premenopausal women's health, inflammatory disease treatment, drug development, investor relations, clinical studies
Funding Rounds & Investors (9)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Post-IPO Equity | •••••• | - | 30 Jan 2024 | |
| Post-IPO Equity | •••••• | - | 23 Oct 2023 | |
| Grant | •••••• | 1 |
|
18 Jan 2023 |
| Post-IPO Equity | •••••• | - | 31 Oct 2022 | |
| Post-IPO Equity | •••••• | - | 08 Dec 2016 |
Palatin Technologies Alternatives & Competitors
For every therapeutic challenge, we question traditional assumptions and find better solutions.
Life sciences company focused on the research and clinical development of therapies for the treatmen...
Improving preclinical and clinical trial success rates with world-leading biomarkers & specialized l...
vs
NRC Research Institute
FAQ About Palatin Technologies
Don't just browse. Track.
Signal Tracker monitors Palatin Technologies and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.